Dr. Heinrich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3710 SW US Veterans Hospital Rd
Portland, OR 97239Phone+1 503-220-8262- Is this information wrong?
Education & Training
Oregon Health & Science UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991- Oregon Health & Science UniversityResidency, Internal Medicine, 1984 - 1988
Johns Hopkins University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 2023 - 2025
OR State Medical License 1985 - 2025
WA State Medical License 2022 - 2025
AK State Medical License 2024 - 2024
ID State Medical License 2022 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
- S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Start of enrollment: 2003 Oct 01
- Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Start of enrollment: 2001 Feb 01
- Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.Mühlenberg, T., Falkenhorst, J., Schulz, T., Fletcher, B., Teuber, A., Krzeciesa, D., Klooster, I., Lundberg, M., Wilson, L., Lategahn, J., von Mehren, M., Grunewald, ...> ;Journal of Clinical Oncology. 2024 Feb 26
- Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, Heather Lin, Behrang Amini, Skye C Mayo, Dejka Araujo, Robert S Benjamin, Anthony P Conley, John A Livingsto...> ;Cancers. 2024 Feb 23
- 3 citationsRipretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.Michael C Heinrich, Robin L Jones, Suzanne George, Hans Gelderblom, Patrick Schöffski, Margaret von Mehren, John R Zalcberg, Yoon-Koo Kang, Albiruni Abdul Razak, Jonat...> ;Nature Medicine. 2024 Feb 1
- Join now to see all
Journal Articles
- Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical AdvancesM C Heinrich, S George, M L Hemming, Annals of Oncology
Lectures
- Clinical activity of avapritinib in ≥ fourth-line (4L+) and PDGFRA Exon 18 gastrointestinal stromal tumors (GIST).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- Clinical activity of avapritinib in ≥ fourth-line (4L+) and PDGFRA Exon 18 gastrointestinal stromal tumors (GIST).2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
Two Studies Seek to Go Beyond the GIST of Intestinal Tract CancerAugust 24th, 2021- The Life Raft Group, a Non-Profit Supporting Patients with GIST Cancer, Announces Members of the 2021 Medical Advisory BoardMarch 16th, 2021
Friday Frontline: Cancer Updates, Research and Education on January 10, 2020January 10th, 2020- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Portland HCSPortland, Oregon
OHSU HospitalPortland, Oregon
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
